Found: 7
Select item for more details and to access through your institution.
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01780-y
- By:
- Publication type:
- Article
LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. N.PAG, doi. 10.1186/s13046-020-01739-z
- By:
- Publication type:
- Article
Catalytic polymer self-cleavage for CO<sub>2</sub> generation before combustion empowers materials with fire safety.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46756-0
- By:
- Publication type:
- Article
Research on new creative conceptual design system using adapted case-based reasoning technique.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice